Lexaria Bioscience Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $2.4M
Liabilities Breakdown FY2018
Total Liabilities: $43.6K
Asset Breakdown
Total Assets: $2.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.7M | 71.0% |
| Accounts Receivable | $265.8K | 10.9% |
| Inventory | $87.2K | 3.6% |
| Property, Plant & Equipment | $1.2K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $146.5K | 6.0% |
| Other Assets | $203.9K | 8.4% |
Liabilities Breakdown
Total Liabilities: $43.6K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $35.8K | 82.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $7.9K | 18.0% |